{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05819775",
            "orgStudyIdInfo": {
                "id": "CSL312_3003"
            },
            "secondaryIdInfos": [
                {
                    "id": "2022-502386-13-00",
                    "type": "CTIS"
                }
            ],
            "organization": {
                "fullName": "CSL Behring",
                "class": "INDUSTRY"
            },
            "briefTitle": "CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema",
            "officialTitle": "A Phase 3 Open-label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema in Pediatric Subjects 2 to 11 Years of Age",
            "therapeuticArea": [
                "Other"
            ],
            "study": "safety-and-pharmacokinetic-study-in-subjects-to-years-of-age-with-hereditary-angioedema"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-11-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-11-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-04",
            "studyFirstSubmitQcDate": "2023-04-17",
            "studyFirstPostDateStruct": {
                "date": "2023-04-19",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "CSL Behring",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to investigate the safety, PK / PD, and efficacy of SC CSL312 for prophylactic treatment of pediatric subjects with HAE."
        },
        "conditionsModule": {
            "conditions": [
                "Hereditary Angioedema (HAE)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "CSL312",
                    "type": "EXPERIMENTAL",
                    "description": "Ages 2-5 years and 6-11 years will have specific subcutaneous dosing schedules",
                    "interventionNames": [
                        "Biological: CSL312"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "CSL312",
                    "description": "Fully human immunoglobulin G subclass 4/lambda recombinant inhibitor monoclonal antibody administered subcutaneously (SC)",
                    "armGroupLabels": [
                        "CSL312"
                    ],
                    "otherNames": [
                        "Garadacimab"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of subjects with treatment emergent adverse events (TEAEs)",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Percent of subjects with TEAEs",
                    "timeFrame": "At lease 14 months"
                },
                {
                    "measure": "Number of TEAEs",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "TEAE rates per injection",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "TEAE rates per subject year",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Maximum concentration (Cmax) of CSL312 at steady-state",
                    "timeFrame": "At least 12 months"
                },
                {
                    "measure": "Trough concentration (Ctrough) of CSL312 at steady-state",
                    "timeFrame": "At least 12 months"
                },
                {
                    "measure": "Time to maximum concentration (Tmax) of CSL312 at steady-state",
                    "timeFrame": "At least 12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Time-normalized number of HAE attacks per month and per year",
                    "timeFrame": "At least 12 months"
                },
                {
                    "measure": "Time-normalized number of HAE attacks treated with on-demand treatment per month and per year",
                    "timeFrame": "At least 12 months"
                },
                {
                    "measure": "Time-normalized number of moderate and / or severe HAE attacks per month and per year",
                    "timeFrame": "At least 12 months"
                },
                {
                    "measure": "Percentage reduction in the time-normalized number of HAE attacks",
                    "timeFrame": "At least 12 months"
                },
                {
                    "measure": "The number of subjects experiencing at least \u2265 50%, \u2265 70%, \u2265 90%, or equal to 100% (attack-free) reduction in the time-normalized number of HAE attacks",
                    "timeFrame": "At least 12 months"
                },
                {
                    "measure": "Number of subjects with serious adverse events (SAEs)",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Percent of subjects with SAEs",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Number of subjects experiencing death",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Percent of subjects experiencing death",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Number of subjects with related TEAEs",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Percent of subjects with related TEAEs",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Number of subjects with TEAEs leading to study discontinuation",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Percent of subjects with TEAEs leading to study discontinuation",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Number of subjects with TEAEs by severity",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Percent of subjects with TEAEs by severity",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Number of subjects with Anti-CSL312 antibodies",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Percent of subjects with Anti-CSL312 antibodies",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Number of subjects with adverse events of special interest (AESIs)",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Percent of subjects with AESIs",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "FXIIa-mediated kallikrein activity",
                    "description": "Blood samples will be collected on the same day as CSL312 administration for assessment of FXIIa-mediated kallikrein activity",
                    "timeFrame": "At least 12 months"
                },
                {
                    "measure": "Number of subjects with laboratory findings reported as AEs",
                    "timeFrame": "At least 14 months"
                },
                {
                    "measure": "Percent of subjects with laboratory findings reported as AEs",
                    "timeFrame": "At least 14 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Male or female\n2. Aged 2 to 11 years, inclusive, with body weight \u2265 10th percentile based on age\n3. Diagnosed with clinically confirmed C1-INH HAE\n4. Experienced \u2265 2 HAE attacks during the 6 months before Screening\n\nExclusion Criteria:\n\n1. Concomitant diagnosis of another form of angioedema, such as idiopathic or acquired angioedema, recurrent angioedema associated with urticaria, or HAE type 3\n2. Use of C1-INH products, androgens, antifibrinolytics, approved or future approved medications, or other small molecule medications for routine prophylaxis against HAE attacks within a minimum of 2 weeks before the Treatment Period\n3. Participation in another interventional clinical study during the 30 days before the Treatment Period or within 5 half-lives of the final dose of the investigational product administered during the previous interventional study, whichever is longer\n4. Having laboratory clinical abnormalities assessed as clinically significant by the investigator in results of hematology or chemistry assessments performed during Screening\n5. Currently receiving a therapy not permitted during the study\n6. Being pregnant or breastfeeding.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "2 Years",
            "maximumAge": "11 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Trial Registration Coordinator",
                    "role": "CONTACT",
                    "phone": "1-610-878-4000",
                    "email": "clinicaltrials@cslbehring.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Study Director",
                    "affiliation": "CSL Behring",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Research Solutions of Arizona",
                    "status": "RECRUITING",
                    "city": "Litchfield Park",
                    "state": "Arizona",
                    "zip": "85340",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.49337,
                        "lon": -112.35794
                    }
                },
                {
                    "facility": "Medical Research of Arizona",
                    "status": "RECRUITING",
                    "city": "Scottsdale",
                    "state": "Arizona",
                    "zip": "85251",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.50921,
                        "lon": -111.89903
                    }
                },
                {
                    "facility": "Donald S. Levy M.D.",
                    "status": "RECRUITING",
                    "city": "Orange",
                    "state": "California",
                    "zip": "92868",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                },
                {
                    "facility": "Raffi Tachdjian MD, Inc.",
                    "status": "RECRUITING",
                    "city": "Santa Monica",
                    "state": "California",
                    "zip": "90404",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.01945,
                        "lon": -118.49119
                    }
                },
                {
                    "facility": "Bernstein Clinical Research",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45236",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "PennState Health Milton S. Hershey Medical Center",
                    "status": "RECRUITING",
                    "city": "Hershey",
                    "state": "Pennsylvania",
                    "zip": "17033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "use central contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.28592,
                        "lon": -76.65025
                    }
                },
                {
                    "facility": "AARA Research Center",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75231",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "use central contact, Dr.",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Campbelltown Hospital, Western Sydney University",
                    "status": "RECRUITING",
                    "city": "Campbelltown",
                    "zip": "NSW 2560",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "use central contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": -34.06667,
                        "lon": 150.81667
                    }
                },
                {
                    "facility": "Ottawa Allergy Research Corp",
                    "status": "RECRUITING",
                    "city": "Ottawa",
                    "zip": "K1H1E4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "use central contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.41117,
                        "lon": -75.69812
                    }
                },
                {
                    "facility": "HZRM H\u00e4mophilie Zentrum Rhein Main GmbH",
                    "status": "RECRUITING",
                    "city": "Frankfurt am Main",
                    "state": "Hesse",
                    "zip": "60596",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "use central contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.11552,
                        "lon": 8.68417
                    }
                },
                {
                    "facility": "Charit\u00e9 - Universit\u00e4tsmedizin Berlin",
                    "status": "RECRUITING",
                    "city": "Berlin",
                    "zip": "12203",
                    "country": "Germany",
                    "contacts": [
                        {
                            "name": "use central contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "Barzilai University Medical Center",
                    "status": "RECRUITING",
                    "city": "Ashkelon",
                    "zip": "7830604",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Use Central Contact",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.66926,
                        "lon": 34.57149
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "CSL will consider on a case-by-case basis requests to share Individual Patient Data (IPD) with external bona-fide, qualified scientific and medical researchers. For information on the process and requirements for submitting a voluntary data sharing request for IPD, please contact CSL at clinicaltrials@cslbehring.com.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP"
            ],
            "timeFrame": "Requests for IPD will generally be considered once review by major regulatory authorities (ie FDA, EMA) is complete and the primary publication is available.",
            "accessCriteria": "Proposed research should seek to answer a previously unanswered important medical or scientific question.\n\nApplicable country specific privacy and other laws and regulations will be considered and may prevent sharing of IPD.\n\nIf the request is approved and the researcher has executed an appropriate data sharing agreement, IPD that has been appropriately anonymized will be available."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000799",
                    "term": "Angioedema"
                },
                {
                    "id": "D000054179",
                    "term": "Angioedemas, Hereditary"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000014581",
                    "term": "Urticaria"
                },
                {
                    "id": "D000017445",
                    "term": "Skin Diseases, Vascular"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000006969",
                    "term": "Hypersensitivity, Immediate"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000081208",
                    "term": "Hereditary Complement Deficiency Diseases"
                },
                {
                    "id": "D000081207",
                    "term": "Primary Immunodeficiency Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000007153",
                    "term": "Immunologic Deficiency Syndromes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4127",
                    "name": "Angioedema",
                    "asFound": "Angioedema",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27584",
                    "name": "Angioedemas, Hereditary",
                    "asFound": "Hereditary Angioedema",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17330",
                    "name": "Urticaria",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19714",
                    "name": "Skin Diseases, Vascular",
                    "relevance": "LOW"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M10020",
                    "name": "Hypersensitivity, Immediate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6879",
                    "name": "Deficiency Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2286",
                    "name": "Hereditary Complement Deficiency Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2285",
                    "name": "Primary Immunodeficiency Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10199",
                    "name": "Immunologic Deficiency Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "T2734",
                    "name": "Hereditary Angioedema",
                    "asFound": "Hereditary Angioedema",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M10122",
                    "name": "Immunoglobulin G",
                    "relevance": "LOW"
                },
                {
                    "id": "M4230",
                    "name": "Antibodies, Monoclonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M19117",
                    "name": "Immunoglobulins, Intravenous",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}